David Steinberg

David Steinberg is a prominent figure in the biotech industry, currently serving as a Board Member and Founding CEO at Carbon Biosciences, a company focused on gene therapy innovations. He is also a General Partner at Longwood Fund, which is known for its investments in biotechnology ventures.

Educational Background

• MBA in Strategy and Finance from the University of Chicago Booth School of Business.
• BA in Biology from Cornell University.

Career Highlights

• Steinberg co-founded Carbon Biosciences, which aims to develop novel parvovirus-derived gene therapies. Under his leadership, the company secured $38 million in Series A financing to advance its therapeutic platforms.12
• He has held leadership roles in several biotech firms, including serving as the founding CEO of companies like Pyxis Oncology, Photys Therapeutics, and Be Biopharma.13
• Prior to his current roles, he was the co-founder and Chief Innovation Officer at PureTech Health, where he focused on launching innovative biotech companies.1

Board Memberships

In addition to his role at Carbon Biosciences, Steinberg serves on the boards of various other biotech companies, including:

• AAVantgarde Bio
• Lassen Therapeutics
• Rectify Pharmaceuticals.14

His extensive experience in biopharma strategy consulting and research & development further solidifies his expertise in the biotechnology sector.